Dizal Pharma: Multiple Research Findings in Lung Cancer Field Selected for Presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting - 7x24

7 x 24 Track global technological trends

Hot Topic

Day

News Topic

Dizal Pharma: Multiple Research Findings in Lung Cancer Field Selected for Presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

1 day ago / Read about 0 minute

Author：小编

Dizal Pharma announced that the company will present the latest research findings on Sunvozertinib®, Govoreztinib®, and DZD6008 in the field of non-small cell lung cancer (NSCLC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held in Chicago from May 29 to June 2. Among these, two studies will be presented in the form of oral reports.

Previous page：As of the end of 2025, SpaceX had approximately US...

Next page：Yuyun Medical Raises Over 100 Million Yuan in Fund...

Return to List

Hot Reading

1 day ago

Framework Laptop 13 Pro is a major overhaul for the modular, upgradeable laptop

2 day ago

NSA spies are reportedly using Anthropic’s Mythos, despite Pentagon feud

2 day ago

Anthropic takes $5B from Amazon and pledges $100B in cloud spending in return

2 day ago

Rahul Rathi Built the Measurement Infra That Strengthened Election Integrity at Meta and Now Shapes Frontier AI Governance